Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Mitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677, RefLevitz SM, et al. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67: 885-890, 1999. PubMed: 9916104 Mitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677
Mukherjee S, et al. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J. Infect. Dis. 173: 1222-1231, 1996. PubMed: 8627076
Levitz SM, et al. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67: 885-890, 1999. PubMed: 9916104
Olszewski MA, et al. Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect. Immun. 69: 6256-6263, 2001. PubMed: 11553568
Mitchell TG, Friedman L. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491-498, 1972. PubMed: 4564677
Levitz SM, et al. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67: 885-890, 1999. PubMed: 9916104
